Tinnitus Clinical Trial
— AudiCogOfficial title:
Cognitive and Emotional Function and Brain Reorganisation Associated to Auditory Abilities : Impact of Tinnitus
the investigators have recently shown that patients with drug-resistant temporal lobe epilepsy who have undergone brain surgery targeting the medial temporal lobe structures were more likely to develop tinnitus postoperatively. This discovery of a vulnerability to tinnitus associated with medial temporal lobe surgery to eliminate drug-refractory epileptic seizures provides a new clinical model of tinnitus, targeting temporal lobe regions as generators or mediators of this hearing disorder. The objective of this project is to study the impact of tinnitus on the cognitive, emotional, psychoacoustic and cerebral functioning associated with this hearing disorder, and to clarify the pathophysiology of tinnitus by comparing different groups of individuals with tinnitus (surgical epileptic patients or non-surgical ORL patients) to matched tinnitus-free groups (surgical tinnitus-free cases and healthy controls volunteer).
Status | Recruiting |
Enrollment | 300 |
Est. completion date | April 15, 2026 |
Est. primary completion date | October 15, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Common Criteria for Inclusion : - Age = 18 years old - Good written and oral comprehension of the French language - Person affiliated to a Social Security scheme - Informed consent signed by the participant - Normal or corrected vision - Absence of known pre-existing neurological and/or degenerative disorders Group Specific Inclusion Criteria : Tinnitus+ Group - Suffering from subjective uni- or bilateral tinnitus, chronic (>3 months) and stable (no period of remission). Chir+ Group - Surgically treated for drug-resistant epilepsy of the temporal lobe (including the amygdala). Group Tinnitus- - Not suffering from tinnitus Group Chir- - Non epileptic - Not having undergone surgical treatment of the temporal lobe (including the tonsil) Exclusion criteria: - Presence of severe or profound deafness, uni or bilateral. - Under legal protection (guardianship, curators, etc.) Additional criteria for patients completing visit V2 : - MRI contraindicated or claustrophobic - Pregnant or breastfeeding woman. |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Européen Georges Pompidou | Paris | |
France | Service de Soins de Suite et Réadaptation (SSR) Neurologique, DMU de Neurosciences | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the impact of tinnitus on executive cognitive functioning | Measurement of executive control using a stroop test in people with and without chronic tinnitus. | at the second visit, maximum 6 month after first visit. | |
Secondary | Emotional functioning (anxiety and depression) | Measures of Anxiety and Depression using: Hospital Anxiety and Depression Scale (HADS) : 14 rated items from 0 to 3. Seven questions are related to anxiety and seven to the depressive dimension, allowing for thus obtaining two scores (maximum score of each score = 21). | at the second visit, maximum 6 month after first visit. | |
Secondary | psycho-acoustic functioning | Measurements of auditory functioning through hearing assessment (audiometry) :
- Self-assessment questionnaires for hearing loss: The self-assessment of hearing loss is based on a yes/no question: "Do you feel that you have a hearing loss or hearing loss? |
at the second visit, maximum 6 month after first visit. | |
Secondary | psycho-acoustic functioning | Measurements of auditory functioning through hearing assessment (audiometry) :
- The noise hypersensitivity questionnaire( Khalfa, 2002) provides a score ranging from 0 (no hypersensitivity) to 42 (very strong hypersensitivity). |
at the second visit, maximum 6 month after first visit. | |
Secondary | psycho-acoustic functioning | Measurements of auditory functioning through hearing assessment (audiometry) :
- The severity of tinnitus is measured by the Tinnitus Handicap Inventory (THI) questionnaire. Scores range from 0 (mild discomfort) to 100 (catastrophic impact). |
at the second visit, maximum 6 month after first visit. | |
Secondary | psycho-acoustic functioning | Measurements of auditory functioning through hearing assessment (audiometry) :
- Hearing threshold measurement (pure tones from 125-16000Hz) |
at the second visit, maximum 6 month after first visit. | |
Secondary | psycho-acoustic functioning | Measurements of auditory functioning through hearing assessment (audiometry) :
- Discomfort threshold measurement (with 1kHz sound) |
at the second visit, maximum 6 month after first visit. | |
Secondary | psycho-acoustic functioning | Measurements of auditory functioning through hearing assessment (audiometry) : Evaluation of transient otoacoustic emissions (TEOAE) or by distortion product (DPOAE) | at the second visit, maximum 6 month after first visit. | |
Secondary | cognitive functioning, other than executive functioning (attention, memory) | Measures of cognitive functioning :
- the Attentional Network Test (ANT) visual attention test. ANT gives three attention scores based on reaction times. These scores represent the ability to direct attention, to be alert to surrounding stimuli and the executive part of attention. |
at the second visit, maximum 6 month after first visit. | |
Secondary | cognitive functioning, other than executive functioning (attention, memory) | Measures of cognitive functioning :
- Mental Flexibility Score (Trail Making Test): The scores of the TMT (Trail Making Test) are expressed in time of completion. The faster the time to completion, the better the performance. So we have 2 scores, one for board A of the test: TMT-A and the other for board B of the test: TMT-B. |
at the second visit, maximum 6 month after first visit. | |
Secondary | cognitive functioning, other than executive functioning (attention, memory) | Measures of cognitive functioning :
Measures of cognitive functioning :- Short-term memory score (auditive-verbal span). Score between 1 and 10, where 10 represents the best short-term memory score |
at the second visit, maximum 6 month after first visit. | |
Secondary | cognitive functioning, other than executive functioning (attention, memory) | Measures of cognitive functioning :
Measures of cognitive functioning :- Working memory score (Brown-Peterson). The Brown Peterson gives a memorization score ranging from 0 to 100, where 100% is the best score. |
at the second visit, maximum 6 month after first visit. | |
Secondary | cognitive functioning, other than executive functioning (attention, memory) | Measures of cognitive functioning :
- Episodic memory score in auditory modality. The episodic memory test in auditory mode gives a memorization score ranging from 0 to 100, where 100% represents a perfect memorization score. |
at the second visit, maximum 6 month after first visit. | |
Secondary | the reorganization of functional and structural brain connectivity maps | Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) :
- Volumetric measurement (in particular of the amygdala and the parahippocampal cortex) |
at the third visit, maximum 18 month after the first visit | |
Secondary | the reorganization of functional and structural brain connectivity maps | Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) :
- Measurement of anatomical connections between regions of interest (i.e. amygdala, auditory cortex, attention network including the precuneus and prefrontal cortex) from diffusion tensor imaging (TDI): fractional anisotropy (FA), mean diffusivity (MD), radial (RD) and axial (AD). |
at the third visit, maximum 18 month after the first visit | |
Secondary | the reorganization of functional and structural brain connectivity maps | Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) :
- Measurement of structural connectivity from fMRI at rest between predefined regions of interest and over new regions of interest defined during an attentional activation task |
at the third visit, maximum 18 month after the first visit | |
Secondary | the reorganization of functional and structural brain connectivity maps | Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) :
- Measurement of the amplitude of the synchrony of slow fluctuations and statistical dependencies in functional connectivity by comparing data from people with and without chronic tinnitus. |
at the third visit, maximum 18 month after the first visit | |
Secondary | Emotional functioning (stress) | Measures of stress using Perceived Stress Scale (PSS-4): Lowest score: 0, Highest score: 16, Higher scores are correlated to more stress. | at the second visit, maximum 6 month after first visit. | |
Secondary | Emotional functioning (Auditory recognition of emotions) | Measures of Auditory recognition of emotions using hearing tests with recordings | at the second visit, maximum 6 month after first visit. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Recruiting |
NCT04987502 -
Virtual Reality and Subjective Tinnitus
|
N/A | |
Recruiting |
NCT04404439 -
Treatment of Tinnitus With Migraine Medications
|
Phase 4 | |
Recruiting |
NCT05533840 -
Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
|
||
Completed |
NCT03552302 -
Effects of Yoga Exercise on Participates With Tinnitus
|
||
Enrolling by invitation |
NCT02617953 -
Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus
|
N/A | |
Withdrawn |
NCT01663467 -
Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
|
N/A | |
Completed |
NCT02974543 -
Somatosensory Stimulation to Alleviate Tinnitus
|
N/A | |
Completed |
NCT02269839 -
A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus
|
N/A | |
Completed |
NCT01929837 -
Tinnitus rTMS 2013
|
N/A | |
Completed |
NCT01857661 -
The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial
|
N/A | |
Completed |
NCT01927991 -
Internet-based Self-help for Tinnitus: The Role of Support
|
N/A | |
Completed |
NCT01480193 -
New Therapy for Patients With Severe Tinnitus
|
N/A | |
Terminated |
NCT01412918 -
Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression
|
N/A | |
Completed |
NCT00748475 -
Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus
|
N/A | |
Completed |
NCT00371436 -
Progressive Intervention Program for Tinnitus Management
|
N/A | |
Completed |
NCT00733044 -
Cost-effectiveness of Multidisciplinary Management of Tinnitus
|
N/A | |
Active, not recruiting |
NCT05518682 -
Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus
|
N/A | |
Recruiting |
NCT05212298 -
Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus
|
N/A | |
Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 |